Neck and décolleté regeneration in women over 45: combined biostimulation protocol

Michele Guariglia

doi:10.57662/am.v11i4.16873

Neck and décolleté regeneration in women over 45: combined biostimulation protocol

Authors

Michele Guariglia Private practice, MG CLINIC, Vallo della Lucania – Salerno, Italy

Keywords:

biostimulation, Radiesse, Platte-rich fibrin, face biostimulation., neck ageing

Abstract

Objectives: Patients over 45 years of age experience aesthetic medicine dynamically. Neck and décolleté represent an area affected by aging: roughness, laxity, redness and blemishes can cause social distress in patients who do not typically cover their neck. Due to the reduction of collagen and elastin, folds and wrinkles are formed with less elastic and toned skin. This is made more noticeable by the effect the sun's UV rays have on unprotected skin. The aim of the study is to evaluate a new neck and décolleté biostimulation protocol with hyaluronic acid, glycerol, and calcium hydroxyapatite.

Materials and methods: 12 patients between 45 and 65 years old were subjected to neck and décolleté treatment with Hyaluronic Acid fillers (20 + 17.5 mg/ml) (Belotero® Revive), for 3 sessions each spaced 20 days apart. One month after the final session, a 1.5 cc injection of calcium hydroxylapatite filler (Radiesse®), diluted at a ratio of 1:3, was administered. Patients were asked if they felt uncomfortable exposing their neckline.

Results: Belotero® Revive improves hydration thanks to the combination of hyaluronic acid and glycerol which has hygroscopic properties. It promotes the absorption of water from the dermis to the stratum corneum; glycerol acts as a protective shield for hyaluronic acid, slowing down its degradation and prolonging its effect. Décolleté wrinkles can be effectively treated with calcium hydroxyapatite which provides an immediate filling effect, therefore reducing their prominence. The calcium hydroxylapatite microspheres contained in the filler stimulate the production of new collagen in the treated area over time. This process helps improve skin quality by promoting regeneration, increasing firmness and elasticity, and evening out skin tone, thereby counteracting the effects of aging and oxidative damage caused by sun exposure. After five months, 75% of the women reported feeling no discomfort when exposing their décolleté, compared to only 20% at the beginning of the treatment.

Conclusions: The combined biostimulation protocol made it possible to obtain important results on the neck and décolleté, redefining the texture, improving brightness, hydration and tone, with extreme relaxation of fine wrinkles and reduction of redness and blemishes. Women over the age of 45 with visible signs of skin aging on the neck and décolleté can achieve significant improvements in this area. As a result, many feel more comfortable wearing necklines they had previously avoided, leading to a sense of rejuvenation, increased self-confidence, and greater self-awareness. The protocol significantly delays the skin aging process.

References

1. Jelaska A, Strehlow D, Korn JH. Fibroblast heterogeneity in physiological conditions and fibrotic disease. Springer Semin Immunopathol. 2000; 21:385-395.

2. Kerscher M, Prager W, Fischer TC et al. Facial skin revitalization with cohesive polydensified Matrix-HA20G: results from a randomized multicenter clinical study. Plast Reconstr Surg Glob Open. 2021; 9(12):e3973.

3. Santoro S, Russo L, Argenzio V, Borzacchiello A. Rheological properties of cross-linked hyaluronic acid dermal fillers. J Appl Biomater Biomech. 2011; 9(2):127-136.

4. Mammucari M, Gatti A, Maggiori S, Bartoletti CA, Sabato AF. Mesotherapy: definition, rationale and clinical role – a consensus report from the Italian Society of Mesotherapy. Eur Rev Med Pharmacol Sci. 2011; 15(6):682-694.

5. Fisher GJ, Varani J, Voorhees JJ. Looking older: fibroblast collapse and therapeutic implications. Arch Dermatol. 2008; 144(5):666-672.

6. Marmur ES, Phelps R, Goldberg DJ. Clinical, histological and electron microscope findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther. 2004; 6(4):223-226.

7. Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg. 2008; 34(Suppl 1):S64-S67.

8. Yutskovskaya YA, Kogan EA, Leshunov E. A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler. J Drugs Dermatol. 2014; 13(9):1047-1052.

9. Bass L, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J. 2010; 30(2):235-238.

10. González N, et al. Evaluation of calcium hydroxylapatite (Radiesse) for facial rejuvenation: a pilot study of volumetric correction in aging face. Dermatol Surg. 2019; 45(4):547-551.

11. Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatol Surg. 2008; 34(Suppl 1):S9-15.

12. van Rozelaar L, Kadouch JA, Duyndam DA, Nieuwkerk PT, Lutgendorff F, Karim RB. Semipermanent filler treatment of HIV-positive patients with facial lipoatrophy: long-term follow-up evaluating MR imaging and quality of life. Aesthet Surg J. 2014; 34(1):118-132.

13. Yutskovskaya YA, Kogan EA. Improved neocollagenesis and skin mechanical properties after injection of diluted calcium hydroxylapatite in the neck and décolletage: a pilot study. J Drugs Dermatol. 2017; 16(1):68-74.

14. Zerbinati N, Calligaro A. Calcium hydroxylapatite treatment of human skin: evidence of collagen turnover through picrosirius red staining and circularly polarized microscopy. Clin Cosmet Investig Dermatol. 2018; 11:29-35.

15. Schachter D, Bertucci V, Solish N. Calcium hydroxylapatite with integral lidocaine provides improved pain control for the correction of nasolabial folds. J Drugs Dermatol. 2016; 15(8):1005-1010.

16. Kim J. Multilayered injection of calcium hydroxylapatite filler on ischial soft tissue to rejuvenate the previous phase of chronic sitting pressure sore. Clin Cosmet Investig Dermatol. 2019; 12:771-784.

17. Distante F, Pagani V, Bonfigli A. Stabilized hyaluronic acid of non-animal origin for rejuvenating the skin of the upper arm. Dermatol Surg. 2009; 35(1):389-394.

18. Reuther T, Bayrhammer J, Kerscher M. Effects of a three-session skin rejuvenation treatment using stabilized hyaluronic acid-based gel of non-animal origin on skin elasticity: a pilot study. Arch Dermatol Res. 2010;302(1):37-45.

19. Lorenc ZP, Black JM, Cheung JS, et al. Skin tightening with hyperdilute CaHa: dilution practices and practical guidance for clinical practice. Aesthet Surg J. 2022; 42(1):29-37.

20. Moers-Carpi M, Vogt S, Santos BM, Planas J, Vallve SR, Howell DJ. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg. 2007; 33(Suppl2):144-151.

21. Ayala F. Fotoinvecchiamento. In: Santoianni P, Monfrecola G, eds. Fotodermatologia. CIC Edizioni Internazionali. Roma. 2003; 55-64.

22. Guinot C, Malvy D-J, Ambroisine L et al. Relative contribution of intrinsic vs extrinsic factors to skin aging as determined by a validated skin age score. Arch Dermatol. 2002; 138(11):1454-1460.

23. Goldie K, Kerscher M, Guillen Fabi S et al. Skin quality – a holistic 360° view: Consensus results. Clin Cosmet Investig Dermatol. 2021; 14:643-654.

24. Figueredo VO, Miot HA, Soares Dias J et al. Efficacy and safety of 2 injection techniques for hand biostimulatory treatment with diluted calcium hydroxylapatite. Dermatologic Surgery. 2020; 46(Suppl1):54-61.

25. Durkin A, Lackey A, Tranchilla A, Poling M, Glassman G, Woltjen N. Single-center, prospective comparison of calcium hydroxylapatite and Vycross-20L in midface rejuvenation: efficacy and patient-perceived value. J Cosmet Dermatol. 2021; 20(2):442-450.

26. Korponyai C, Szél E, Behány Z et al. Effects of locally applied glycerol and xylitol on hydration, barrier function and morphological parameters of the skin. Acta Derm Venereol. 2017; 97(2):182-187.

27. Belmontesi M, De Angelis F, Di Gregorio C et al. Injectable non-animal stabilized hyaluronic acid as a skin quality booster: an expert panel consensus. J Drugs Dermatol. 2018; 17(1):83-88.

28. Fluhr JW, Darlenski R, Surber C. Glycerol and the skin: holistic approach to its origin and functions. Br J Dermatol. 2008; 159(1):23-34.

29. Schwartz J, Friedman AJ. Exogenous factors in skin barrier repair: review and clinical applications. J Drugs Dermatol. 2016;15(11):1289-1294.

30. Succi IB, da Silva RT, Orofino-Costa R. Rejuvenation of periorbital area: treatment with an injectable nonanimal non-crosslinked glycerol added hyaluronic acid preparation. Dermatol Surg. 2012; 38(2):192-198.

31. Kerscher M, Bayrhammer J, Reuther T. Rejuvenating influence of a stabilized hyaluronic acid-based gel of non-animal origin on facial skin aging. Dermatol Surg. 2008;34(5):720-726.

32. Hertz-Kleptow D, Hanschmann A, Hofmann M, Reuther T, Kerscher M. Facial skin revitalization with CPM®-HA20G: an effective and safe early intervention treatment. Clin Cosmet Investig Dermatol. 2019; 12:563-572.

33. Pavicic T. Complete biodegradable nature of CaHA after injection for malar enhancement: an MRI study. Clin Cosmet Investig Dermatol. 2015; 8:19-25.